Clinical and Epidemiological Study on Tubercular Uveitis in a Tertiary Eye Care Centre in Italy

Purpose To describe frequency, clinical characteristics, and visual prognosis of tubercular uveitis (TBU) in a nonendemic country. Methods We retrospectively reviewed 3743 charts of patients with endogenous uveitis visited from 2008 to 2018 at a tertiary referral centre in Rome, Italy. We included immunocompetent patients with diagnosis of TBU. Patients were divided in two groups: patients with history of uveitis without a previous diagnosis of TBU (group A) and patients at their first episode of TB uveitis (group B). Results TBU was diagnosed in 28 (0.75%) out of 3743 patients. Twelve (42.9%) patients came from tuberculosis endemic areas. All patients received specific antitubercular treatment (ATT) and were evaluated for a mean follow-up of 3.2 ± 2.9 years. Group A showed a greater number of ocular complications when compared with group B. ATT was effective in reducing the frequency of recurrences of uveitis in patients of group B. Conclusion Intraocular inflammation can be the first manifestation of tuberculosis. Our data highlight that early diagnosis and specific treatment of TBU may allow to decrease recurrences and to improve visual outcomes.

[1]  R. Chaisson,et al.  Building a tuberculosis-free world: The Lancet Commission on tuberculosis , 2019, The Lancet.

[2]  P. Sève,et al.  Tuberculose oculaire , 2018, La Revue de Médecine Interne.

[3]  R. Agrawal,et al.  Visual Morbidity and Ocular Complications in Presumed Intraocular Tuberculosis: An Analysis of 354 Cases from a Non-Endemic Population , 2018, Ocular immunology and inflammation.

[4]  R. Agrawal,et al.  Global Variations and Challenges With Tubercular Uveitis in the Collaborative Ocular Tuberculosis Study. , 2018, Investigative ophthalmology & visual science.

[5]  S. Zweifel,et al.  Review of people with retinal vasculitis and positive QuantiFERON®-TB Gold test in an area nonendemic for tuberculosis , 2018, International Ophthalmology.

[6]  Xiaoxuan Liu,et al.  A retrospective cohort study of patients treated with anti-tuberculous therapy for presumed ocular tuberculosis , 2017, Journal of Ophthalmic Inflammation and Infection.

[7]  R. Duarte,et al.  Ocular tuberculosis: Position paper on diagnosis and treatment management. , 2017, Revista portuguesa de pneumologia.

[8]  M. Ang,et al.  Controversies in ocular tuberculosis , 2016, British Journal of Ophthalmology.

[9]  Cecilia S Lee,et al.  Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis. , 2016, Survey of ophthalmology.

[10]  P. Tortorella,et al.  Follow-Up Study of Over Three Years of Patients with Uveitis after Cataract Phacoemulsification: Outcomes and Complications , 2015, Seminars in ophthalmology.

[11]  D. Albert,et al.  Ocular Tuberculosis , 2016, Microbiology spectrum.

[12]  Faiz I Shakarchi,et al.  Ocular tuberculosis: current perspectives , 2015, Clinical ophthalmology.

[13]  J. Sahel,et al.  Ocular tuberculosis: experience of an Italian and French cohort , 2015, Acta ophthalmologica.

[14]  P. Tortorella,et al.  Spectral domain optical coherence tomography imaging of tubercular chorioretinitis and intraretinal granuloma. Intraretinal tuberculosis: a case report , 2015, International Ophthalmology.

[15]  C. Tu,et al.  Risk of cataract for people with tuberculosis: results from a population-based cohort study. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[16]  M. Khairallah,et al.  Clinics of Ocular Tuberculosis , 2015, Ocular immunology and inflammation.

[17]  J. Rosenbaum,et al.  Diagnosis and Treatment for Ocular Tuberculosis among Uveitis Specialists: The International Perspective , 2015, Ocular immunology and inflammation.

[18]  J. Rosenbaum,et al.  Lack of Consensus in the Diagnosis and Treatment for Ocular Tuberculosis among Uveitis Specialists , 2015, Ocular immunology and inflammation.

[19]  A. Rothova,et al.  Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. , 2014, American journal of ophthalmology.

[20]  A. Sattin,et al.  Tuberculosis of the eye in Italy: a forgotten extrapulmonary localization , 2014, Infection.

[21]  A. Bruscolini,et al.  Uveitis preceding Crohn’s disease by 8 years , 2011, International Ophthalmology.

[22]  N. Rao,et al.  Ocular tuberculosis: a clinicopathologic and molecular study. , 2011, Ophthalmology.

[23]  P. Karakousis,et al.  Intraocular Tuberculosis , 2010, Ocular immunology and inflammation.

[24]  L. Cimino,et al.  Tuberculous uveitis, a resurgent and underdiagnosed disease , 2009, International Ophthalmology.

[25]  Vishali Gupta,et al.  Intraocular tuberculosis--an update. , 2007, Survey of ophthalmology.

[26]  J. Biswas,et al.  Ocular morbidity in patients with active systemic tuberculosis , 1995, International Ophthalmology.

[27]  L. Tomazzoli,et al.  Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. , 2001, Acta ophthalmologica Scandinavica.

[28]  B. Bodaghi,et al.  Ocular tuberculosis. , 2000, Current opinion in ophthalmology.

[29]  L. Soto-Ramírez,et al.  [Treatment of tuberculosis]. , 1997, Gaceta medica de Mexico.

[30]  M. Accorinti,et al.  Endogenous uveitis: an analysis of 1,417 cases. , 1996, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[31]  R. Nussenblatt,et al.  International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. , 1987, American journal of ophthalmology.